Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H24N2OS.ClH |
Molecular Weight | 376.943 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCNC1=CC=C(C)C2=C1C(=O)C3=CC=CC=C3S2
InChI
InChIKey=LAOOXBLMIJHMFO-UHFFFAOYSA-N
InChI=1S/C20H24N2OS.ClH/c1-4-22(5-2)13-12-21-16-11-10-14(3)20-18(16)19(23)15-8-6-7-9-17(15)24-20;/h6-11,21H,4-5,12-13H2,1-3H3;1H
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C20H24N2OS |
Molecular Weight | 340.482 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Lucanthone is a thioxanthenone DNA intercalator. It inhibits topoisomerases and the dual function base excision repair enzyme apurinic endonuclease 1. Lucanthone has been devised for the treatment of schistosomiasis. It is also an antitumor agent. Lucanthone was being developed by Spectrum Pharmaceuticals for the treatment of malignant brain tumours.
Originator
Approval Year
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
96 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/9989518/ |
10 mg/kg 1 times / 2 days steady-state, oral dose: 10 mg/kg route of administration: Oral experiment type: STEADY-STATE co-administered: |
LUCANTHONE serum | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
PubMed
Title | Date | PubMed |
---|---|---|
Accelerated regression of brain metastases in patients receiving whole brain radiation and the topoisomerase II inhibitor, lucanthone. | 1999 Jan 1 |
|
Clonogenicity of human leukemic cells protected from cell-lethal agents by heat shock protein 70. | 2005 Spring |
|
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. | 2007 Jun-Aug |
|
Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. | 2010 |
|
[(1,2,5,6-η)-1,5-Cyclo-octa-diene](1-isopropyl-3-methyl-imidazolin-2-yl-idene)(triphenyl-phosphine)iridium(I) tetra-fluorido-borate dichloro-methane solvate. | 2010 Aug 18 |
|
2-Butyl-11-phenyl-5,10-dihydro-1H-benzo[e]imidazo[1,5-a][1,4]diazepine-1,3(2H)-dione. | 2010 Feb 13 |
|
2-Propyl 3,3-dibromo-2-hydroxy-pyrrolidine-1-carboxyl-ate. | 2010 Feb 13 |
|
Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. | 2011 Feb 25 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:55 GMT 2023
by
admin
on
Fri Dec 15 15:12:55 GMT 2023
|
Record UNII |
918K9N56QZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
||
|
NCI_THESAURUS |
C250
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6920
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | Merck Index | ||
|
14574
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
7095
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
DTXSID20878506
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
918K9N56QZ
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL279014
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
548-57-2
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
C76055
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
11054
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
DBSALT000826
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY | |||
|
208-951-5
Created by
admin on Fri Dec 15 15:12:55 GMT 2023 , Edited by admin on Fri Dec 15 15:12:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |